Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Clin Cancer Res. 2014 Sep 15;20(21):5435–5445. doi: 10.1158/1078-0432.CCR-14-0542

Figure 3. dCK expression in gemcitabine resistant bladder cancer cell lines.

Figure 3

A) Western blot of protein expression in CAL29 and RT112 cells treated with increasing doses of either gemcitabine or dFdU over several passages until resistant to 10 μM drug (n=2).

B) Quantitative PCR of dCK expression in gemcitabine resistant cells at the mRNA level (* denotes significance of P < 0.001).